# Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease

> **NCT00781417** · NA · COMPLETED · sponsor: **Atlanta VA Medical Center** · enrollment: 48 (actual)

## Conditions studied

- Kidney Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin D
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00781417
- **Lead sponsor:** Atlanta VA Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-10
- **Final completion:** 2011-12
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00781417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00781417, "Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00781417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*